Navigation Links
Chimerix Presents Data Highlighting Burden Of Care Associated With Current Antiviral Therapies In Stem Cell Transplantation
Date:9/21/2012

negatively impact both stem cell and organ transplant recipients.  CMX001 has demonstrated clinical activity in the prevention of CMV infection and preemption of AdV infection post-HSCT.

The data presented were derived from CMX001 Study 201*, Chimerix's Phase 2 study evaluating CMX001 for the prevention of CMV disease in HSCT recipients.  The subset of patients described above received placebo or an inactive, low dose of CMX001.

Chimerix is planning to explore further the potential benefit of CMX001 in efficacy and safety, and reducing the burden of care. Chimerix is initiating a Phase 3 clinical trial of CMX001 for the prevention of CMV infection in adult CMV seropositive HSCT recipients, in which all subjects will be followed through 24 weeks post-transplant.

About Chimerix and CMX001
Chimerix is developing novel oral antiviral therapeutics with the potential to improve outcomes for patients in multiple therapeutic areas, including transplant, oncology, acute care and global health.  The company's proprietary lipid technology has given rise to two clinical-stage lipid acyclic nucleoside phosphonates, CMX001 and CMX157, which have demonstrated the potential for enhanced activity and safety compared with currently approved drugs. 

CMX001 is a novel, broad-spectrum, oral antiviral that inhibits dsDNA viruses, including CMV, AdV, BK virus and herpes simplex virus.  CMX001 has completed Phase 2 clinical development for the prophylaxis of CMV in HSCT recipients and is in Phase 2 development for the preemption and treatment of AdV infection.  To date, more than 800 patients have been dosed with CMX001 in controlled clinical trials and open-label treatment protocols.  Chimerix has completed an End of Phase 2 meeting with the FDA and is preparing to initiate Phase 3 clinical development of CMX001 for the prophylaxis of CMV in HSCT recipients in early 2013.   

In addition to its co
'/>"/>

SOURCE Chimerix, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Chimerix Signs Worldwide License Agreement With Merck For CMX157, A Novel Candidate For The Treatment Of HIV
2. Chimerixs Broad Spectrum Antiviral Therapeutic, CMX001, Demonstrates Potential To Mitigate BK Virus Associated End-Organ Disease In Clinical Study
3. Chimerix Announces BK Virus Data In Late-Breaking Poster Session At The 24th International Congress Of The Transplantation Society
4. Jennerex Presents Positive Clinical Data from Phase 2 Trial of JX-594 in Sorafenib-Refractory Liver Cancer Patients
5. Sorbent Therapeutics Presents CLP1001 Phase 2a Study Results at the 16th Annual Meeting of the Heart Failure Society of America
6. Mettler Toledo Presents In-depth Guidance to Comply with New USP Chapters 41 and 1251 on Balances Used for Quantitative Analysis in the Pharma QC Lab
7. Elevation Pharmaceuticals Presents Positive Phase 2b Results for EP-101 in COPD Patients at the European Respiratory Society Annual Congress
8. Informex Global Pharma Sourcing 2012 Presents Key Strategies & Insight For Business Success
9. Epigenomics Presents Significant Opportunities for Investment and Product Development, According to New Biotech Market Research
10. Cardium Presents Second Quarter 2012 Financial Results And Reports On Recent Developments
11. Inovio Initiates H1N1 Universal Influenza Vaccine Clinical Trial Targeting Over-65 Population, Which Represents 90% of Flu Deaths
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... , July 30, 2015 ... research report with market overview, trends, DRO ... porter analysis, recent developments, competitive scenario and ... Industry Insight: Biosensors Market Development and Demand ... http://photos.prnewswire.com/prnh/20150727/756778 ) Explore more ...
(Date:7/30/2015)... 30, 2015 Global ENT ... to reach USD 23.01 million in 2022, according to ... base of geriatric population, increasing prevalence of ear, nose, ... of awareness among target customer base are expected serve ... forecast period. According to estimates published by the WHO, ...
(Date:7/30/2015)... , July 30, 2015  Lannett Company, Inc. ... will present at the Canaccord Genuity 35th Annual Growth ... Eastern at the InterContinental Boston Hotel.  ... www.lannett.com .  Listeners are encouraged to visit the ... start of the presentation to register, download and install ...
Breaking Medicine Technology:Global Biosensors Market (Size of $12,964 Million in 2014) to Witness 10% CAGR During 2015 - 2020 2Global Biosensors Market (Size of $12,964 Million in 2014) to Witness 10% CAGR During 2015 - 2020 3Global Biosensors Market (Size of $12,964 Million in 2014) to Witness 10% CAGR During 2015 - 2020 4Global Biosensors Market (Size of $12,964 Million in 2014) to Witness 10% CAGR During 2015 - 2020 5ENT Devices Market Size to Reach $23.01 Billion by 2022: Grand View Research, Inc. 2ENT Devices Market Size to Reach $23.01 Billion by 2022: Grand View Research, Inc. 3ENT Devices Market Size to Reach $23.01 Billion by 2022: Grand View Research, Inc. 4ENT Devices Market Size to Reach $23.01 Billion by 2022: Grand View Research, Inc. 5
... leading platform for automated revenue and charge capture processes, ... Store for iPhone, iPod touch and iPad. The application ... at the Hospital Information and Management Systems Society (HIMSS) ... access the charge and data capture platform virtually anywhere. ...
... Ind., Feb. 17, 2011 Symmetry Medical Inc. (NYSE: ... the global orthopaedic device industry and other medical markets, announced ... 1, 2011. Symmetry anticipates full year 2010 ... guidance of $360 to $364 million. For ...
Cached Medicine Technology:HIMSS11: Ingenious Med Launches Billing and Data Capture App for iPhone, iPod touch and iPad 2Symmetry Medical Announces Preliminary Unaudited Full Year 2010 Revenue 2Symmetry Medical Announces Preliminary Unaudited Full Year 2010 Revenue 3
(Date:7/31/2015)... (PRWEB) , ... July 31, 2015 , ... ... distribution of a wide variety of nutritional and wellness products, announced the addition ... that specializes in massage therapy, active isolated stretching and the prevention and rehabilitation ...
(Date:7/31/2015)... ... 2015 , ... India Network Foundation sponsors visitor health insurance program ... visit for the past 25 years. As India Network offers coverage for all age ... spend time with their children and grand children. India Network specializes in covering ...
(Date:7/31/2015)... ... 2015 , ... People love to feel like they are ... is an important factor to clients when choosing to purchase a policy. This ... Producer Multi-Life Discount program, where advisers pass savings onto their clients. , "The ...
(Date:7/31/2015)... Orange, NJ (PRWEB) , ... July 31, 2015 ... ... obstructive sleep apnea (OSA) and the growing number of individuals who remain undiagnosed, ... of Americans continue to shy away from traditional CPAP therapy due to its ...
(Date:7/30/2015)... , ... July 30, 2015 , ... Dale Sky Jones, ... States, will speak at the International Cannabis Professionals Expo held at the Caribe Royal ... The International Cannabis Professionals Expo is the largest medical cannabis expo in ...
Breaking Medicine News(10 mins):Health News:NPI Welcomes Vincent Aquilino to Board of Directors 2Health News:India Network Visitor Health Insurance Announces Completion of Food Grains Distribution to Godavari Pushkaram Visitors, Andhra Pradesh, India 2Health News:India Network Visitor Health Insurance Announces Completion of Food Grains Distribution to Godavari Pushkaram Visitors, Andhra Pradesh, India 3Health News:Secura Consultants Gives Advisers Competitive New Edge with Multi-Life Discount Program 2Health News:Oravan Sleep Apnea Device Gains Traction in Sleep Industry 2Health News:Finally…First Ever Professional Training Event for Doctors and Nurses Wanting to Offer Medical Marijuana Recommendations to Patients 2Health News:Finally…First Ever Professional Training Event for Doctors and Nurses Wanting to Offer Medical Marijuana Recommendations to Patients 3Health News:Finally…First Ever Professional Training Event for Doctors and Nurses Wanting to Offer Medical Marijuana Recommendations to Patients 4Health News:Finally…First Ever Professional Training Event for Doctors and Nurses Wanting to Offer Medical Marijuana Recommendations to Patients 5
... and Drug Administration (FDA) has recommended that a certain type ... prescribing the drug clopidogrel to identify individuals who may be ... previous studies did not find an overall significant association between ... in the December 28 issue of JAMA . ...
... Dec. 27 (HealthDay News) -- New research finds some ... you will make you stronger. While extremely harrowing ... can cause psychological damage, less drastic life challenges can ... of the University at Buffalo. In one study, ...
... obstacle to developing an HIV vaccine A ... the STEP study was halted in September 2007 after ... Moreover, subsequent analyses indicated that the vaccine made some ... had pre-existing immune effectors (antibodies) that recognized a component ...
... elderly have slower response times when they have to make ... that much of that slower response is a conscious choice ... people can be trained to respond faster in some decision-making ... in this area aren,t so different from younger adults. ...
... Dec. 26 (HealthDay News) -- Teens are more likely to ... their mother when they were toddlers, according to a new ... who didn,t have close emotional ties with their parents were ... 4.5 years old. In the latest study, researchers examined ...
... The quality of the emotional relationship between a mother ... that child to be obese during adolescence, a new ... characteristics between mothers and their children during their toddler ... terms of the child,s emotional security and the mother,s ...
Cached Medicine News:Health News:Analysis does not support genetic test before use of anti-clotting drug 2Health News:Analysis does not support genetic test before use of anti-clotting drug 3Health News:Adversity, Trauma May Boost Mental Toughness 2Health News:JCI online early table of contents: Dec. 27, 2011 2Health News:JCI online early table of contents: Dec. 27, 2011 3Health News:JCI online early table of contents: Dec. 27, 2011 4Health News:JCI online early table of contents: Dec. 27, 2011 5Health News:JCI online early table of contents: Dec. 27, 2011 6Health News:JCI online early table of contents: Dec. 27, 2011 7Health News:JCI online early table of contents: Dec. 27, 2011 8Health News:Elderly can be as fast as young in some brain tasks, study shows 2Health News:Elderly can be as fast as young in some brain tasks, study shows 3Health News:Elderly can be as fast as young in some brain tasks, study shows 4Health News:Mother-Toddler Bond May Influence Teen Obesity 2Health News:Study links quality of mother-toddler relationship to teen obesity 2Health News:Study links quality of mother-toddler relationship to teen obesity 3Health News:Study links quality of mother-toddler relationship to teen obesity 4
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: